Calnexin anticorps
Aperçu rapide pour Calnexin anticorps (ABIN6942330)
Antigène
Voir toutes Calnexin (CANX) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Réactivité croisée
- Humain, Rat
-
Purification
- Purified by Protein A.
-
Immunogène
- C terminus human Calnexin
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
WB 1:300-5000
FCM 1:20-100
IHC-P 1:200-400
IF(ICC) 1:50-200
IHC() -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 1xTBS ( pH 7.4), 1 % BSA, 40 %Glycerol and 0.05 % Sodium Azide.
-
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
-
Date de péremption
- 12 months
-
-
- Calnexin (CANX)
-
Autre désignation
- Calnexin
-
Sujet
-
Synonyms: Calnexin, IP90, Major histocompatibility complex class I antigen-binding protein p88, p90, CANX
Background: Calcium-binding protein that interacts with newly synthesized glycoproteins in the endoplasmic reticulum. It may act in assisting protein assembly and/or in the retention within the ER of unassembled protein subunits. It seems to play a major role in the quality control apparatus of the ER by the retention of incorrectly folded proteins. Associated with partial T-cell antigen receptor complexes that escape the ER of immature thymocytes, it may function as a signaling complex regulating thymocyte maturation. Additionally it may play a role in receptor-mediated endocytosis at the synapse.
-
ID gène
- 821
-
UniProt
- P27824
-
Pathways
- Signalisation MAPK, Thyroid Hormone Synthesis
Antigène
-